EFFECTOR THERAPEUTICS
eFFECTOR is a clinical stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs). eFFECTOR’s STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The eIF4F complex is a central node where two of the most frequently mutated signaling pathways in cancer, the PI3K-AKT and RAS-MEK pathways, converge to activate the tra... nslation of select messenger RNA into proteins that are frequent culprits in key disease driving processes. Each of eFFECTOR’s product candidates is designed to act on a single protein that drives the expression of multiple functionally related proteins, including oncoproteins and immunosuppressive proteins in T cells, that together control tumor growth, survival and immune evasion. eFFECTOR’s lead product candidate, tomivosertib, is a MNK 1/2 inhibitor. KICKSTART, a randomized, double-blind, placebo controlled Phase 2b trial of tomivorsertib in NSCLC in combination with pembrolizumab is currently open for enrollment. Zotatifin, eFFECTOR’s inhibitor of eIF4A, is currently in the dose-escalation portion of a Phase 1/2 trial, with Phase 2a expansion cohorts expected to initiate in the second half of 2021. eFFECTOR has a global collaboration with Pfizer to develop inhibitors of a third target, eIF4E.
EFFECTOR THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2012-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.effector.com
Total Employee:
11+
Status:
Active
Contact:
8589258215
Email Addresses:
[email protected]
Total Funding:
220.02 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Domain Not Resolving Euro Organization Schema
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Alpine Immune Sciences
Alpine Immune Sciences is an immunotherapy startup focused on developing recombinant, protein-based therapeutic solutions.
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Avila Therapeutics
Avila Therapeutics is a biotechnology company focused on the development of covalent drugs to treat cancer and other autoimmune diseases.
Biotheranostics
Biotheranostics is a commercial-stage molecular diagnostics company that support physicians in the treatment of cancer patients.
Black Diamond Therapeutics
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.
BlueLight Therapeutics
BlueLight Therapeutics uses a proprietary structure-based platform to discover small molecules against difficult-to-drug targets.
CoapTech
CoapTech is an early-stage medical device company aiming to improve medical care delivery for patients young and old around the world.
Divide and Conquer
Divide & Conquer is a biotechnology company focused on discovery and development of a new class of oncology therapeutics
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Elysium Therapeutics
Elysium Therapeutics is a health care company that focuses on biotechnology, fitness, medical, and robotics.
Exuma Biotech
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.
Galapagos
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Lengo Therapeutics
Lengo Therapeutics a biopharmaceutical company focused on the discovery and development of cancer treatments.
Lynx Biosciences
Lynx Biosciencesis a clinical-stage biotechnology company.
MabSpace Biosciences
MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.
MEI Pharma
MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Nabsys
Nabsys is a life sciences company focused on the development of solid-state, single-molecule positional sequencing technology.
New Horizon Health
New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.
NiKang Therapeutics
NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Praxis Precision Medicines
Praxis Precision Medicines offers drug development services.
Prothena
Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.
Rafael Holdings
Rafael Holdings is a company focused on the development of novel cancer therapies.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Santi Therapeutics
Santi Therapeutics is a pharmaceutical company that focuses on the research and development of small molecule therapeutics.
Syantra
Syantra is a precision healthcare company that focuses on the commercialization of breast cancer detection blood tests.
Valo Health
Valo Health uses human-centric data and machine learning-anchored computation to transform the drug discovery and development process.
XinThera
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
The Column Group
The Column Group investment in Post-IPO Equity - Effector Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Post-IPO Equity - Effector Therapeutics
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Post-IPO Equity - Effector Therapeutics
Abingworth
Abingworth investment in Post-IPO Equity - Effector Therapeutics
SR One
SR One investment in Post-IPO Equity - Effector Therapeutics
BioMed Ventures
BioMed Ventures investment in Post-IPO Equity - Effector Therapeutics
Sectoral Asset Management
Sectoral Asset Management investment in Post-IPO Equity - Effector Therapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Post-IPO Equity - Effector Therapeutics
U.S. Venture Partners
U.S. Venture Partners investment in Post-IPO Equity - Effector Therapeutics
Pfizer Venture Investments
Pfizer Venture Investments investment in Post-IPO Equity - Effector Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-08-08 | eFFECTOR Therapeutics Appoints Douglas Warner, M.D., as Chief Medical Officer |
Official Site Inspections
http://www.effector.com Semrush global rank: 7.22 M Semrush visits lastest month: 555
- Host name: 209.182.196.37
- IP address: 209.182.196.37
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045